DOJ Sues Pharmaceutical Giant AmerisourceBergen for ‘Fueling the Opioid Epidemic’

Company accused of distributing "hundreds of thousands" of opioid pills to pharmacies that it knew or should have known were being diverted for illegal use

The U.S. Department of Justice (DOJ) has filed a lawsuit against AmerisourceBergen, one of the largest pharmaceutical distributors in the country, for alleged opioid violations. The lawsuit claims that the company distributed “hundreds of thousands” of opioid pills to pharmacies that it knew, or should have known, were being diverted for illegal use.

The lawsuit, filed in federal court in Cleveland, Ohio, alleges that AmerisourceBergen “failed to report suspicious orders of opioids and filled those orders, despite red flags indicating the drugs were being misused.” The suit also accuses the company of “knowingly and intentionally causing false and fraudulent claims to be submitted to federal healthcare programs for payment.”

According to the lawsuit, AmerisourceBergen distributed “hundreds of thousands” of oxycodone and hydrocodone pills to pharmacies in Ohio, West Virginia, and Kentucky between 2008 and 2012. The suit claims that the company “failed to report suspicious orders of opioids and filled those orders, despite red flags indicating the drugs were being misused.”

In a statement, U.S. Attorney Vanita Gupta said, “AmerisourceBergen is alleged to have ignored red flags that its drugs were being misused and abused, and instead, chose to flood communities with opioids.” She added that the company’s actions “fueled the opioid epidemic and caused immeasurable harm.”

The lawsuit comes as part of the federal government’s ongoing efforts to hold pharmaceutical companies accountable for their role in the opioid epidemic. The opioid crisis has resulted in hundreds of thousands of deaths and has had a devastating impact on communities across the country.

AmerisourceBergen has denied the allegations and said in a statement that it “has been and remains committed to doing our part to combat the opioid epidemic.” The company added that it “has taken significant steps to strengthen our compliance programs, including enhancing our surveillance and analytics capabilities.”

In conclusion, The U.S. Department of Justice (DOJ) has filed a lawsuit against AmerisourceBergen, one of the largest pharmaceutical distributors in the country, for alleged opioid violations. The lawsuit claims that the company distributed “hundreds of thousands” of opioid pills to pharmacies that it knew, or should have known, were being diverted for illegal

By Robert Hornberg

Robert Hornberg is a seasoned journalist and visionary editor who brings a wealth of experience and a passion for storytelling to his role as the Managing Editor of the United States Daily Globe. With over a decade of experience in the field, he has honed his skills in uncovering captivating stories and leading teams to produce outstanding content. Prior to joining the United States Daily Globe, Robert worked as a foreign correspondent, traveling the world to cover underreported stories and gaining a unique perspective on the human experience. He is a native of the Pacific Northwest, and his love for the great outdoors has led him to pursue a variety of outdoor activities, including hiking, camping, and fishing. In his free time, he is an avid sports fan, and he loves nothing more than cheering on the Seattle Seahawks and the Seattle Mariners. He is also a proud parent to two young children and a dedicated husband to his wife. His commitment to journalistic integrity and his tireless work ethic have earned him recognition within the industry.

You May Also Like

  • עתידו של יאיר אדיבי: השאיפות והאתגרים הבאים

  • The Ascendance of Faith-Based Health and Diet Programs

  • Navigating the Road to Recovery

  • IIRM-URA Unveils Advanced Drone Technology for Nuclear Threat Detection